以肠道菌群为靶点治疗肠易激综合征的研究进展

被引：24

作者：

赵萌 ^{[1
]}

李岩 ^{[2
]}

机构：

[1] 中国医科大学第二临床学院

[2] 中国医科大学附属盛京医院消化内科

来源：

胃肠病学和肝病学杂志 | 2017年 / 26卷 / 05期

关键词：

肠易激综合征; 治疗; 肠道菌群; 粪菌移植; 益生菌; 幽门螺杆菌;

D O I：

暂无

中图分类号：

R574.4 [肠道功能紊乱];

学科分类号：

100201 [内科学];

摘要：

肠易激综合征(irritable bowel syndrome,IBS)是一种病因不明的功能性肠病,主要表现为腹痛和排便习惯的改变。肠道菌群紊乱是IBS的重要发病原因之一,通过粪菌移植(fecal microbiota transplantation,FMT)、补充益生菌、艾灸刺激调节肠道菌群和根除幽门螺杆菌(Helicobacter pylori,H.pylori)均能对IBS的症状起到缓解作用。本文就IBS、肠道菌群紊乱和以肠道菌群为靶点治疗IBS的研究进展作一概述。

引用

页码：487 / 490

页数：4

共 26 条

[1]

Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis [J].

Zhuang, Xiaojun ;

Xiong, Lishou ;

Li, Li ;

Li, Manying ;

Chen, Minhu .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (01) :28-38

[2]

Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook [J].

Kelly, Colleen R. ;

Kahn, Stacy ;

Kashyap, Purna ;

Laine, Loren ;

Rubin, David ;

Atreja, Ashish ;

Moore, Thomas ;

Wu, Gary .

GASTROENTEROLOGY, 2015, 149 (01) :223-237

[3]

Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress [J].

Sundin, J. ;

Rangel, I. ;

Fuentes, S. ;

Heikamp-de Jong, I. ;

Hultgren-Hornquist, E. ;

de Vos, W. M. ;

Brummer, R. J. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (04) :342-351

[4]

Manipulation of the Microbiota for Treatment of IBS and IBD-Challenges and Controversies [J].

Shanahan, Fergus ;

Quigley, Eamonn M. M. .

GASTROENTEROLOGY, 2014, 146 (06) :1554-1563

[5]

Therapeutic faecal microbiota transplantation: current status and future developments [J].

Borody, Thomas J. ;

Brandt, Lawrence J. ;

Paramsothy, Sudarshan .

CURRENT OPINION IN GASTROENTEROLOGY, 2014, 30 (01) :97-105

[6]

Fecal microbiota transplantation: Indications, methods, evidence, and future directions [J].

Borody T.J. ;

Paramsothy S. ;

Agrawal G. .

Current Gastroenterology Reports, 2013, 15 (8)

[7]

A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome [J].

Kruis, Wolfgang ;

Chrubasik, Sigrun ;

Boehm, Stephan ;

Stange, Christiane ;

Schulze, Juergen .

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (04) :467-474

[8]

Gastrointestinal Microbiome Signatures of Pediatric Patients With Irritable Bowel Syndrome [J].

Saulnier, Delphine M. ;

Riehle, Kevin ;

Mistretta, Toni-Ann ;

Diaz, Maria-Alejandra ;

Mandal, Debasmita ;

Raza, Sabeen ;

Weidler, Erica M. ;

Qin, Xiang ;

Coarfa, Cristian ;

Milosavljevic, Aleksandar ;

Petrosino, Joseph F. ;

Highlander, Sarah ;

Gibbs, Richard ;

Lynch, Susan V. ;

Shulman, Robert J. ;

Versalovic, James .

GASTROENTEROLOGY, 2011, 141 (05) :1782-1791

[9]

Regulation of Tight Junction Permeability by Intestinal Bacteria and Dietary Components1;2.[J].Ulluwishewa; Dulantha;Anderson; Rachel C;McNabb; Warren C;Moughan; Paul J;Wells; Jerry M;Roy; Nicole C.The Journal of Nutrition.2011, 5

[10]

Review article: probiotics and prebiotics in irritable bowel syndrome [J].

Spiller, R. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (04) :385-396

← 1 2 3 →